Product NDC: | 46783-161 |
Proprietary Name: | Xeomin |
Non Proprietary Name: | incobotulinumtoxinA |
Active Ingredient(s): | 50 [USP'U]/1 & nbsp; incobotulinumtoxinA |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 46783-161 |
Labeler Name: | Merz Aesthetics. Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA125360 |
Marketing Category: | BLA |
Start Marketing Date: | 20110801 |
Package NDC: | 46783-161-01 |
Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (46783-161-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE |
NDC Code | 46783-161-01 |
Proprietary Name | Xeomin |
Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (46783-161-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE |
Product NDC | 46783-161 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | incobotulinumtoxinA |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 20110801 |
Marketing Category Name | BLA |
Labeler Name | Merz Aesthetics. Inc |
Substance Name | BOTULINUM TOXIN TYPE A |
Strength Number | 50 |
Strength Unit | [USP'U]/1 |
Pharmaceutical Classes | Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA] |